BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients

Breast Cancer Res · 2011 · PMC3247056

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

a strong trendP = 0.053so close (0.05 < p ≤ 0.1)

A lower p53/chromosome 17 ratio correlated with higher grading ( P = 0.003) and showed a strong trend toward HER1/chromosome 7 ratio ( P = 0.053).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.